Benjamin J. Zeskind - Feb 8, 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
PRESIDENT AND CEO, Director, 10%+ Owner
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
Stock symbol
IMRX
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 04:07 PM
Previous filing
Feb 17, 2023
Next filing
Mar 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +244K $0.00 244K Feb 8, 2024 Class A Common Stock 244K $6.09 Direct F1
transaction IMRX Stock Option Award $0 +16.4K $0.00 16.4K Feb 8, 2024 Class A Common Stock 16.4K $6.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.